This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.
Screening a neuroactive drug library to identify new treatments for Parkinson’s Investments < €500k United Kingdom 2016
Characterisation of the long-term prognosis of Parkinson’s and development of statistical models to predict prognosis Investments < €500k United Kingdom 2016
Glucocerebrosidase chaperones in Parkinson’s Investments < €500k United Kingdom 2016
Understanding the genome-wide gene expression landscape in Dementia with Lewy Bodies Investments < €500k United Kingdom 2016
Modifing the exosomal release of alpha synuclein as a potential target to prevent disease progression in Parkinson’s Investments < €500k United Kingdom 2016
The integration of biomedical research, describing the biological processes relevant to Parkinson’s, into the Gene Ontology database Investments < €500k United Kingdom 2016
Single-centre open label exploratory phase two pilot study of exogenous oral Melatonin for the treatment of nocturia in Parkinson’s Investments < €500k United Kingdom 2016
CRISPR-Cas9 genetic screens for genes conferring survival to oxidative stress in dopamine neurons Investments < €500k United Kingdom 2016
Can we safely treat and monitor people with Parkinson’s in Tanzania: A model for sub-Saharan Africa? Investments < €500k United Kingdom 2016
Predicting dementia in Parkinson’s: A genotypic and phenotypic study Investments < €500k United Kingdom 2016
